Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2009 / Cilt: 19 - Sayı: 2

The prognostic significance of comorbidity and relation of comorbidity with the other prognostic factors in patients with non small cell lung cancer

Küçük hücreli dışı akciğer kanserinde komorbiditenin prognostik önemi ve diğer prognostik faktörlerle ilişkisi

Pages
63–68
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Univariate analysis demonstrated significant associations between overall survival and comorbidity, as well as, age, disease stage, performans status and histopathological type (p= 0.00001).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Comorbidities often be encountered in lung cancer patients.
📊
Key Findings & Data:In this study, the prevelance of comorbidity in 358 patients with non small cell lung cancer diagnosed in Gülhane Military Medical Academy Haydarpaşa Training Hospital was reviewed and its association with other known prognostic factors and impact of comorbidity on the prognosis was investigated.
💡
Conclusion & Impact:Univariate analysis demonstrated significant associations between overall survival and comorbidity, as well as, age, disease stage, performans status and histopathological type (p= 0.00001).
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Eş tanı · Yaş faktörü · Karsinom

Abstract

Comorbidities often be encountered in lung cancer patients. However, the relationship between lung cancer and comorbidity has not been investigated sufficiently yet. In this study, the prevelance of comorbidity in 358 patients with non small cell lung cancer diagnosed in Gülhane Military Medical Academy Haydarpaşa Training Hospital was reviewed and its association with other known prognostic factors and impact of comorbidity on the prognosis was investigated. Comorbidity was significantly correlated with age, disease stage and performance status (p= 0.0001). There was no association of comorbidity grade with sex and histopathological type (p= 0.9, p= 0.5). Univariate analysis demonstrated significant associations between overall survival and comorbidity, as well as, age, disease stage, performans status and histopathological type (p= 0.00001). In multivariate analysis, high comorbidity grade, as independent from the other prognostic factors, influences overall survial negatively (p= 0.0001). As a result, it was found that comorbidity is an independent poor prognostic factor in patients with non small cell lung cancer.

Özet

Akciğer kanseri hastalarında komorbidite sık görülmektedir. Ancak, akciğer kanseri ve komorbidite arasındaki ilişki bugüne kadar yeterince araştırılmamıştır. Bu çalışmada, GATA Haydarpaşa Eğitim Hastanesinde küçük hücreli dışı akciğer kanseri tanısı konmuş 358 hastadaki komorbidite sıklığı incelenmiş, komorbiditenin diğer bilinen prognostik faktörlerle ilişkisi ve prognostik önemi araştırılmıştır. Komorbiditenin tanımlanmasında ve derecelendirilmesinde Charlson komorbidite indeksi kullanılmıştır. Komorbidite derecesi ile yaş, evre ve performans durumu arasında anlamlı bir korelasyon bulunmuştur (p= 0.0001). Komorbidite derecesi ile cinsiyet ve histopatolojik tip arasında ise anlamlı bir korelasyon bulunamamıştır (p= 0.9, p= 0.5). Tek değişkenli analizde komorbidite derecesi, yaş, evre, performans durumu ve histopatolojik tip ile genel sağkalım arasında anlamlı bir ilişki olduğu bulunmuştur (p= 0.00001). Çok değişkenli analizde ise, yüksek komorbidite derecesinin diğer faktörlerden bağımsız olarak genel sağkalımı olumsuz yönde etkilediği bulunmuştur (p= 0.0001). Sonuç olarak, küçük hücreli dışı akciğer kanseri hastalarında komorbiditenin diğer prognostik faktörlerden bağımsız olarak kötü prognostik bir faktör olduğu bulunmuştur.

🔖

Cite This Article

ÖZGÜN, M. A., KARAGÖZ, B., BİLGİ, O., KANDEMİR, E. G., TÜRKEN, O. (2009). The prognostic significance of comorbidity and relation of comorbidity with the other prognostic factors in patients with non small cell lung cancer. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 19 - Sayı: 2, 63–68. https://ajindex.com/articles/323208

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Landis SH, Murray T, Bolden S, et al. Cancer statistics 1999. CA Cancer J Clin 49: 8-31, 1999
  2. Janssen-Heijnen ML, Schipper RM, Razenberg PP, et al. Prevalence of comorbidity in lung cancer patients and its relationship with treatment: A population-based study. Lung Cancer 21: 105-113, 1998
  3. Janssen-Heijnen ML, Smulders S, Lemmens VE, et al. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 59: 602-607, 2004
  4. Tammemagi CM, Neslund-Dudas C, Simoff M, et al. Impact of comorbidity on lung cancer survival. Int J Cancer 103: 792-802, 2003
  5. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and Validation. J Chronic Dis 40: 373-83, 1987
  6. Sobue T, Suzuki T, Fujimoto I, et al. Prognostic factors for surgically treated lung adenocarcinoma patients with special reference to smoking habit. Jpn J Cancer Res 82: 33-39, 1991
  7. Harpole DH, Herndon JE, Wolfe WG, et al. A Prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology and oncoprotein expression. Cancer Res 55: 51-56, 1995
  8. Langendijk JA, Thunnissen FB, Lamers RJ, et al. The prognostic significance of accumulation of p53 protein in stage III non-small cell lung cancer treated by radiotherapy. Radiother Oncol 36: 218-224, 1995
  9. Tammemagi M, McLaughlin J, Mullen J, et al. Study of smoking, p53 tumor suppressor gene alterations and non-small cell lung cancer. Ann Epidemiol 10: 176-185, 2000
  10. Caro JJ, Salas M, Ward A, et al. Anemia as an independent prognostic factor for survival in patients with cancer. Cancer 91: 2214-2221, 2001
  11. Schrijvers CT, Coebergh JW, Mackenbach JP, et al. Socioeconomic status and comorbidity among newly diagnosed cancer patients. Cancer 80: 1482-1488, 1997
  12. Ogle KS, Swanson GM, Woods N, et al. Cancer and comorbidity: Redefining chronic diseases. Cancer 88: 53-63, 2000
  13. Lopez-Encuentra A. Comorbidity in operable lung cancer: A multicenter descriptive study on 2992 patients. Lung Cancer 35: 263-269, 2002
  14. Yancik R, Kessler L, Yates JW, et al. The elderly population: Opportunities for cancer prevention and detection. Cancer 62: 1823-1828, 1988.